£179.99

Springer Metabolic Syndrome: An Important Risk Factor for Stroke, Alzheimer Disease, and Depression

Price data last checked 20 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£180 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 71 days • 71 data points (No recent data available)

Historical
Generating forecast...
£179.99 £170.99 £174.59 £178.19 £181.79 £185.39 £188.99 23 March 2026 09 April 2026 27 April 2026 14 May 2026 01 June 2026

Price Distribution

Price distribution over 71 days • 1 price levels

Days at Price
71 days 0 18 36 53 71 £180 Days at Price

Price Analysis

Most common price: £180 (71 days, 100.0%)

Price range: £180 - £180

Price levels: 1 different prices over 71 days

Description

This book offers comprehensive detail and cutting edge research on connections between metabolic syndrome and stroke, Alzheimer's disease and depression, benefiting postgraduate students, instructors, researchers, pharmacologists, nutritionists and physicians. From the Back Cover The metabolic syndrome is a cluster of common pathologies: abdominal obesity linked to an excess of visceral fat, insulin resistance, dyslipidemia and hypertension. At the molecular level, metabolic syndrome is accompanied not only by dysregulation in the expression of adipokines, cytokines, and chemokines but also by alterations in insulin and leptin signaling, oxidative stress, and chronic low grade inflammation. These changes affect immune responses and mediate chronic inflammation leading to alterations in the hypothalamic ‘bodyweight/appetite/satiety set point’. It is becoming increasingly evident that metabolic syndrome is a risk factor for neurological disorders such as stroke, depression, and Alzheimer disease (AD). Family history, age, environmental and lifestyle factors (diet and physical inactivity, and exposure to toxins) are closely associated with predisposition for the development of metabolic syndrome as well as neurological disorders. The incidences of stroke are 2 to 4-fold higher in patients with metabolic syndrome and cardiovascular diseases compared to normal subjects of the same age. Similarly, patients with metabolic syndrome have a 2 to 3-fold increased risk for developing dementia and AD. Metabolic syndrome doubles the risk of depression. The molecular mechanism underlying the mirror relationship between metabolic syndrome and neurological disorders is not fully understood. However, biochemical alterations observed in metabolic syndrome like induction of chronic inflammation and oxidative stress, impairment of endothelial cell function, induction of insulin and leptin resistance, hyperglycemia-related increase in advanced glycation end-products, and micro-vascular injury may represent a pathological bridge between metabolic syndrome and neurological disorders. It is hoped that Metabolic Syndrome: An important risk factor for stroke, Alzheimer disease, and depression will be useful to postgraduate students, faculty, research scientists, pharmacologists, nutritionists, and physicians, who are curious about the molecular mechanisms that link metabolic syndrome with stroke, Alzheimer disease, and depression.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

High Calorie Diet and the Human Brain: Metabolic Consequences of Long-Term Consumption
85% match

High Calorie Diet and the Human Brain: Metabolic Consequences of Long-Term Consumption

Springer

£76.98 24 May 2026
Oxidative Stress, Inflammation and Angiogenesis in the Metabolic Syndrome
83% match

Oxidative Stress, Inflammation and Angiogenesis in the Metabolic Syndrome

Springer

£107.98 31 May 2026
Diabetes, Insulin and Alzheimer's Disease (Research and Perspectives in Alzheimer's Disease)
81% match

Diabetes, Insulin and Alzheimer's Disease (Research and Perspectives in Alzheimer's Disease)

Springer

£107.78 31 May 2026
The Metabolic Syndrome: Pharmacology and Clinical Aspects
81% match

The Metabolic Syndrome: Pharmacology and Clinical Aspects

Springer

£128.31 27 May 2026
Connections, Cognition and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)
80% match

Connections, Cognition and Alzheimer’s Disease (Research and Perspectives in Alzheimer's Disease)

Springer

£77.85 20 May 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
79% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£117.61 11 May 2026
Overweight and the Metabolic Syndrome:: From Bench to Bedside: 26 (Endocrine Updates, 26)
79% match

Overweight and the Metabolic Syndrome:: From Bench to Bedside: 26 (Endocrine Updates, 26)

Springer

£107.98 26 May 2026
Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders: 1134 (Advances in Experimental Medicine and Biology, 1134)
79% match

Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders: 1134 (Advances in Experimental Medicine and Biology, 1134)

Springer

£107.98 04 May 2026
79% match

Building Blocks of Neuroimmunometabolism: From Molecular Pathways to Therapeutic Strategies

Academic Press

£157.99 20 May 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
78% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£111.83 26 May 2026
Alzheimer’s Disease. Epidemiology, Neuropathology, Neurochemistry, and Clinics (Key Topics in Brain Research)
78% match

Alzheimer’s Disease. Epidemiology, Neuropathology, Neurochemistry, and Clinics (Key Topics in Brain Research)

Springer

£50.88 26 May 2026
Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics: 824 (Advances in Experimental Medicine and Biology, 824)
78% match

Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics: 824 (Advances in Experimental Medicine and Biology, 824)

Springer

£87.64 01 Jun 2026
Metabonomics and Gut Microbiota in Nutrition and Disease (Molecular and Integrative Toxicology)
78% match

Metabonomics and Gut Microbiota in Nutrition and Disease (Molecular and Integrative Toxicology)

Springer

£76.38 02 Jun 2026
A Systems Biology Approach to Study Metabolic Syndrome
78% match

A Systems Biology Approach to Study Metabolic Syndrome

Springer

£107.98 06 Jun 2026
Neuro-Immune Interactions in Neurologic and Psychiatric Disorders (Research and Perspectives in Neurosciences)
78% match

Neuro-Immune Interactions in Neurologic and Psychiatric Disorders (Research and Perspectives in Neurosciences)

Springer

£73.85 11 Jun 2026
Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management (Current Clinical Neurology)
78% match

Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management (Current Clinical Neurology)

Humana

£80.65 22 May 2026
Molecular Basis of Health and Disease
77% match

Molecular Basis of Health and Disease

Springer

£110.00 21 May 2026
Obesity and Brain Function: 19 (Advances in Neurobiology, 19)
77% match

Obesity and Brain Function: 19 (Advances in Neurobiology, 19)

Springer

£107.85 30 May 2026
Depressive Disorders: Mechanisms, Measurement and Management: 1180 (Advances in Experimental Medicine and Biology, 1180)
77% match

Depressive Disorders: Mechanisms, Measurement and Management: 1180 (Advances in Experimental Medicine and Biology, 1180)

Springer

£74.71 20 May 2026
Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)
77% match

Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)

Springer

£141.23 24 May 2026
Meltdown and the Neuroscience of Stress
77% match

Meltdown and the Neuroscience of Stress

Cambridge Scholars Publishing

£58.99 08 Jun 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
77% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£143.49 24 May 2026
Chronobiology and Obesity
77% match

Chronobiology and Obesity

Springer

£106.68 26 May 2026
Research Progress in Alzheimer's Disease and Dementia: v. 3 (Nova Biomedical): Volume 3
77% match

Research Progress in Alzheimer's Disease and Dementia: v. 3 (Nova Biomedical): Volume 3

£110.40 30 May 2026